×

ImmuDyne (OTCQB: IMMD) Announces Investor Awareness Campaign, Anticipates Strong Growth

MT. KISCO, N.Y., June 27, 2013 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) announced today that the Company is launching an investor awareness campaign beginning on July 9, 2013 and continuing throughout 2013. The Company will be implementing strategies and tactics designed to increase market awareness of ImmuDyne and its product portfolio, among strategic investors, institutions and analysts.

Mark McLaughlin, President and CEO, stated: "We are initiating an IR campaign as one of several steps we will be taking to foster company growth and increase shareholder awareness. During recent months significant progress has been made in identifying strategic partners and distribution channels for our product lines."

Karen Kingston, Chief Marketing Officer, stated: "I am pleased with the consumer and industry response we have received to our new product lines and branding, specifically Primed For Immunity™ (PFI™). We recently held our first PFI Experience Event with Kandy Magazine in Hollywood at the Drais on June 14, 2013. The PFI product, branding, and messaging were received with excitement and enthusiasm. Strong interest was expressed in establishing a strategic partnership from a potential distribution partner and in setting up a US and global network for the PFI product. We will be holding several other events in the Hollywood area this summer to increase demand of this breakthrough product. However, the big picture is the science behind our flagship beta 1/3,1/6 d-glucan product, PURACERE™. We will continue to educate consumers and strategic partners about the critical responsibilities of the immune system and how PURACERE's proprietary beta 1/3,1/6 d-glucan formulation naturally primes the immune system. Notably, the immune system is crucial in regulating the body's energy, weight, inflammation, skin, and even mood. As ImmuDyne continues to move forward with our business plan, PURACERE's applications across dozens of multi-billion dollar therapeutic and wellness markets will become more evident."

About Primed For Immunity™

Primed For Immunity™ (PFI) is a dietary supplement that naturally primes the immune system with PURACERE™. Clinical studies have shown that a hangover is not exclusively caused by dehydration and/or congeners, but also by the changing levels of cytokines in the body due to immune suppression. PURACERE is a natural dietary supplement that is the purist beta-1,3/1,6-D-glucan available. Beta-1,3/1,6-D-glucans directly bind with immune system cells to activate protective immune responses through the release of cytokines. For more information, please visit www.PFIclub.com.

About ImmuDyne

ImmuDyne is a wellness lifestyle company. ImmuDyne has a portfolio of unique patent-protected products with applications in the wellness lifestyle, skin care, anti-aging, fitness, and health care markets. ImmuDyne has offices located in Mt. Kisco, NY, Carlsbad, CA, and Florence, KY.

Primed For Immunity, PFI, and PURACERE are trademarks of ImmuDyne, Inc.

ImmuDyne shares trade under the ticker symbol IMMD and the Company can be found on the web at www.immudyne.com.

Cautionary language regarding Forward-Looking Statements Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Certain statements in this press release may contain words such as "anticipates," "believes," "could," "estimates," "expects," "intends," "may," "projects," "plans," "targets" and other similar language and are considered forward-looking statements. These statements are based on management's current expectations, estimates, and forecasts. These forward-looking statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and therefore the actual results may be materially different from those discussed.

CONTACT: ImmuDyne, Inc. Mark McLaughlin +1-914-714-8901 MarkMcL@immudyne.comSource:ImmuDyne, Inc.